Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical ...

Referral to a PH expert centre, including for right heart catheterisation, confirms the diagnosis. Supportive measures include diuretic therapy for symptoms of right heart failure and fluid retention, ...

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered ...

Sotatercept-csrk is approved for improving exercise capacity and reducing clinical worsening in PAH patients, following FDA ...

November is Pulmonary Hypertension Awareness Month, and the American Lung Association, with support from Merck, is raising ...

Dr. Sathish Kumar Krishnan has spent years tackling a silent crisis in healthcare: pulmonary hypertension (PH), a condition that affects thousands but remains underdiagnosed and under-treated. As a ...

Pulmonary hypertension remains one of the most challenging and underdiagnosed conditions in respiratory medicine. However, with a well-structured approach and dedicated efforts, significant ...

Positive topline data from Part B of the TX45 Phase 1b trial demonstrated improvements in both left heart function and pulmonary hemodynamics in ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $41.0, a ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello. I'm Dr. Vallerie McLaughlin from the University of Michigan. And welcome to this edition of Medscape InDiscussion series on ...